Compare Terrascend Corp. with Similar Stocks
Stock DNA
Other Agricultural Products
CAD 342 Million (Small Cap)
NA (Loss Making)
NA
0.00%
1.95
-24.95%
2.56
Revenue and Profits:
Net Sales:
92 Million
(Quarterly Results - Dec 2025)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.93%
0%
-15.93%
6 Months
-20.83%
0%
-20.83%
1 Year
46.15%
0%
46.15%
2 Years
-60.25%
0%
-60.25%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Terrascend Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.51%
EBIT Growth (5y)
25.90%
EBIT to Interest (avg)
-0.20
Debt to EBITDA (avg)
4.32
Net Debt to Equity (avg)
1.06
Sales to Capital Employed (avg)
0.75
Tax Ratio
45.85%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
7.90%
ROCE (avg)
3.58%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.56
EV to EBIT
10.52
EV to EBITDA
7.31
EV to Capital Employed
1.53
EV to Sales
1.61
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.53%
ROE (Latest)
-24.95%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Sideways
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bearish
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 4 Foreign Institutions (7.9%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
92.20
89.70
2.79%
Operating Profit (PBDIT) excl Other Income
20.40
21.30
-4.23%
Interest
13.50
12.70
6.30%
Exceptional Items
-4.50
-1.40
-221.43%
Consolidate Net Profit
-0.70
-13.60
94.85%
Operating Profit Margin (Excl OI)
155.30%
171.10%
-1.58%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 2.79% vs -0.33% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 94.85% vs -52.81% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
364.10
367.30
-0.87%
Operating Profit (PBDIT) excl Other Income
86.40
79.70
8.41%
Interest
50.70
47.00
7.87%
Exceptional Items
-6.90
-3.70
-86.49%
Consolidate Net Profit
-34.20
-28.60
-19.58%
Operating Profit Margin (Excl OI)
171.30%
154.30%
1.70%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -0.87% vs -14.24% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -19.58% vs 74.26% in Dec 2024
About Terrascend Corp. 
Terrascend Corp.
Other Agricultural Products
TerrAscend Corp is a Canada-based company engaged in providing products, brands, and services to the cannabinoid market. The Company, through its subsidiary TerrAscend Canada Inc., is a producer of medical and adult use cannabis. It also operates through various businesses, including The Apothecarium, a cannabis dispensary with retail locations in California and Nevada; Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ascendant Laboratories Inc., a biotechnology and licensing company focused on cannabinoid expressing plants; Solace RX Inc., a Drug Preparation Premises (DPP) focused on the development of formulations and delivery forms; and Valhalla Confections, a manufacturer of premium cannabis-infused edibles.
Company Coordinates 
Company Details
3610 Mavis Rd , MISSISSAUGA ON : L5B 4A7
Registrar Details






